Search

Nina Webster

Dr Nina Webster has more than 12 years of senior executive experience, including leading investor relations and business development activities in biotech companies, in a career that spans over 25 years globally in the pharmaceutical and biotechnology industry. She began her career in new product development with Wyeth Pharmaceuticals (now part of Pfizer) in the UK before moving to Australia. Dr Webster was the commercial director of Acrux where she was responsible for the strategic identification, development and maintenance of commercial partnerships globally, the intellectual property portfolio and investor relations. She also had a lead role in multiple commercial transactions with global pharmaceutical companies that collectively netted over $300 million in revenue to date, and she prosecuted several complex US-based intellectual property matters. Prior to that she was the director of Commercialisation & IP for Immuron. Dr Webster holds a PhD in Pharmaceutics (Drug Delivery) from Cardiff University, a Bachelors Degree in Pharmacology, a Masters Degree in Intellectual Property Law from Melbourne University, and an MBA from RMIT.
Bio last updated 01 Sep 2018

Access to our data for Nina Webster is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Nina Webster is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
391stPointerra0%-13%
464thHazer Group-7%0%
564thDimerix-21%-5%
799thSkin Elements-71%0%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Roles

2018
Chief Executive, Managing Director
Year started and most recent title

Revenue

165th↑Pointerra$840k
166th-Skin Elements$838k
167th↓Dimerix$825k
168th↑Hazer Group$759k
169th↓Grandbridge$703k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer